Key result
The LDL-C/HDL-C ratio continues to be a valuable and standard tool to evaluate cardiovascular disease risk, serving as a practical alternative to apolipoprotein-based guidelines.
Why the study?
Is the LDL-C/HDL-C ratio a valuable tool to evaluate cardiovascular disease risk compared to apolipoprotein-based measurements?
Is the LDL-C/HDL-C ratio a valuable tool to evaluate cardiovascular disease risk compared to apolipoprotein-based measurements?
The LDL-C/HDL-C ratio remains a practical and valuable tool for evaluating CVD risk, especially given the familiarity of cholesterol-based guidelines compared to apolipoprotein terminology.
No takes yet. Share an insight, caveat, or question.
Supports LDL-C/HDL-C ratio use in practice; leaves open whether apolipoproteins offer superior prediction.
Fernández et al. (2008) conducted a review in Cardiovascular disease risk. LDL-C/HDL-C ratio vs. Apolipoprotein B/A-I ratio was evaluated. The LDL-C/HDL-C ratio continues to be a valuable and standard tool to evaluate cardiovascular disease risk, serving as a practical alternative to apolipoprotein-based guidelines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: